dose proportionality
Showing 1 - 25 of >10,000
MDD (MDD Trial in Ahmedabad (Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 5mg, Vortioxetine Hemihydrobromide
Active, not recruiting
- Major Depressive Disorder (MDD
- Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 5mg
- +2 more
-
Ahmedabad, Gujarat, IndiaCliantha Research Limited
Oct 24, 2022
Heart Failure Trial in Mönchengladbach (BAY94-8862 (1.25mg), BAY94-8862 (2.5mg), BAY94-8862 (5mg))
Completed
- Heart Failure
- BAY94-8862 (1.25mg)
- +4 more
-
Mönchengladbach, Nordrhein-Westfalen, GermanyCRS Clinical-Research-Services Mönchengladbach GmbH
Jan 27, 2022
Healthy Volunteers Trial in Las Vegas (Maribavir (400 mg), Maribavir (200 mg), Maribavir (800 mg))
Completed
- Healthy Volunteers
- Maribavir (400 mg)
- +2 more
-
Las Vegas, NevadaPPD Development, LP
Feb 5, 2022
Endometriosis Trial in Mannheim (BAY2328065, Placebo)
Completed
- Endometriosis
- BAY2328065
- Placebo
-
Mannheim, Baden-Württemberg, GermanyCRS Clinical-Research-Services Mannheim GmbH
May 30, 2022
Healthy Participants Trial in Lenexa (BMS-986165 Tablet formulation 1, BMS-986165 Tablet formulation 2)
Completed
- Healthy Participants
- BMS-986165 Tablet formulation 1
- BMS-986165 Tablet formulation 2
-
Lenexa, KansasPRA Health Sciences - Lenexa
Nov 9, 2021
Antifungal Agents Trial in Navi Mumbai (Griseofulvin 500 mg, Griseofulvin 250 mg, Reference Griseofulvin 500 mg)
Completed
- Antifungal Agents
- Griseofulvin 500 mg
- +2 more
-
Navi Mumbai, IndiaGSK Investigational Site
Dec 1, 2020
Healthy Volunteers Trial in Miami (Maribavir)
Terminated
- Healthy Volunteers
-
Miami, FloridaClinical Pharmacology of Miami, Llc
Dec 22, 2020
Fibrosis Trial in Randwick (BLD-2660)
Withdrawn
- Fibrosis
-
Randwick, New South Wales, AustraliaScientia Clinical Research
Oct 29, 2020
Healthy Volunteers Trial in Evansville (CC-292, Oral Omeprazole (OMP))
Completed
- Healthy Volunteers
- CC-292
- Oral Omeprazole (OMP)
-
Evansville, IndianaCovance Clinical Research unit
Aug 11, 2020
Healthy Subjects Trial in Quebec City (TNX-102 SL)
Completed
- Healthy Subjects
- TNX-102 SL
-
Quebec City, Quebec, CanadaCanada, Quebec
Jan 3, 2020
Alzheimer's Disease Trial in San Antonio (PU-AD, Placebo)
Completed
- Alzheimer's Disease
- PU-AD
- Placebo
-
San Antonio, TexasICON Early Phase Services
Nov 14, 2022
HIV Trial in Las Vegas (Cabotegravir 200 mg/mL, Cabotegravir 400 mg/mL, Recombinant human hyaluronidase PH20 (rHuPH20))
Recruiting
- HIV Infections
- Cabotegravir 200 mg/mL
- +2 more
-
Orlando, Florida
- +3 more
Dec 1, 2022
Rheumatoid Arthritis Trial in Groningen (SOL-116, Placebo)
Recruiting
- Rheumatoid Arthritis
- SOL-116
- Placebo
-
Groningen, NetherlandsQPS Netherlands B.V.
Oct 20, 2022
Healthy Subjects, Opioid Antagonist, Pharmacokinetics Trial in West Bend (Four naloxone nasal spray doses (1 every 2.5 min),
Completed
- Healthy Subjects
- +2 more
- Four naloxone nasal spray doses (1 every 2.5 min)
- +2 more
-
West Bend, WisconsinSpaulding Clinical Research
Mar 17, 2022
Migraine With Aura, Migraine Without Aura, Migraine Trial in Miami (Dihydroergotamine)
Completed
- Migraine With Aura
- +2 more
-
Miami, FloridaQuotient Sciences Miami Inc.
Nov 25, 2019
Opioid Withdrawal (Disorder) Trial (Standard of Care with Lofexidine, Standard of Care without Lofexidine)
Not yet recruiting
- Opioid Withdrawal (Disorder)
- Standard of Care with Lofexidine
- Standard of Care without Lofexidine
- (no location specified)
Sep 14, 2023
Novel Approaches for Quantitative Assessment of Adherence
Active, not recruiting
- Healthy
- Adenine 5+ (five stable-labeled nitrogens)
-
Aurora, ColoradoUniversity of Colorado- Anschutz Medical Campus
May 2, 2022
Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult Trial in Germany (IMA401 (Phase Ia), IMA401 (Phase Ib))
Recruiting
- Refractory Cancer
- +3 more
- IMA401 (Phase Ia)
- IMA401 (Phase Ib)
-
Tübingen, Baden-Wurttemberg, Germany
- +16 more
Dec 19, 2022